The Prognostic Implications of FIX and FLO Patterns in Mucinous Colon Carcinomas.


Journal

Journal of gastrointestinal cancer
ISSN: 1941-6636
Titre abrégé: J Gastrointest Cancer
Pays: United States
ID NLM: 101479627

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 30 1 2018
medline: 30 8 2019
entrez: 30 1 2018
Statut: ppublish

Résumé

Colon mucinous carcinomas (MUCs) have two morphological patterns: (i) glands lined by mucinous epithelium with direct contact to the stroma (FIX) and (ii) carcinoma cells floating in mucin (FLO). In this study, we evaluated the prognostic value of these patterns. Digital images were captured from the 38 MUC's tissue sections. A grid with 140 points was laid over the computer screen. Totally, 100 points, falling on tumor cells floating in mucin (FLO patterned cells) or on cells contacting stroma (FIX patterned cells), were counted. Tumors were grouped according to the median value of the FIX patterned cells. Cases with more than this value were grouped as FIX and less were grouped as FLO cases. The prognostic value of FIX and FLO pattern was evaluated. The median for FIX patterned cells was 66%, and the cases with lower values than this were grouped as FLO (N = 18; 47.37%), while the rest were grouped as FIX cases. There was no significant difference between FIX and FLO cases for overall survival cases (p = 0.167). For FIX cases, 62.7 and 51.3% of the patients were alive at second and third years, while this was 78.9 and 72.4% for the FLO group, respectively. This is the first study using a quantitative methodology depending on count pointing to evaluate FIX/FLO feature of MUCs to the best of our knowledge, although we could not observed any prognostic and clinicopathologic relationship statistically. This distinctive feature should be studied in larger cohorts with prognostic information, with a quantitative method, like the one that was applied in this study, in order to achieve strict conclusions.

Identifiants

pubmed: 29376207
doi: 10.1007/s12029-018-0059-6
pii: 10.1007/s12029-018-0059-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-259

Références

Histopathology. 2000 Feb;36(2):121-6
pubmed: 10672056
Cancer. 2000 Apr 1;88(7):1739-57
pubmed: 10738234
Arch Pathol Lab Med. 2000 Jul;124(7):979-94
pubmed: 10888773
Clin Otolaryngol Allied Sci. 2001 Dec;26(6):442-6
pubmed: 11843920
Am J Clin Pathol. 2002 Jun;117(6):908-15
pubmed: 12047142
Dis Colon Rectum. 2003 Feb;46(2):160-7
pubmed: 12576888
J Pathol. 2003 Jul;200(4):429-47
pubmed: 12845611
Neuroradiology. 2003 Dec;45(12):896-9
pubmed: 13680031
Clin Cancer Res. 2003 Nov 15;9(15):5660-5
pubmed: 14654549
Hepatogastroenterology. 2004 Jan-Feb;51(55):142-6
pubmed: 15011850
Mod Pathol. 2004 Jun;17(6):696-700
pubmed: 15017435
J Clin Pathol. 2005 Jan;58(1):32-8
pubmed: 15623479
Tech Coloproctol. 2004 Nov;8 Suppl 1:s123-5
pubmed: 15655594
Ann Oncol. 2005 Aug;16(8):1305-10
pubmed: 15857840
Pathol Int. 2005 Dec;55(12):766-74
pubmed: 16287491
J Oral Sci. 2006 Sep;48(3):139-43
pubmed: 17023746
Cell Oncol. 2007;29(5):387-98
pubmed: 17726261
Ann Surg Oncol. 2008 May;15(5):1429-39
pubmed: 18301950
Br J Cancer. 2009 Mar 24;100(6):881-7
pubmed: 19259089
Chin Med J (Engl). 2009 Jul 5;122(13):1486-91
pubmed: 19719934
Eur J Cancer. 2010 Mar;46(4):720-8
pubmed: 20044247
Int J Colorectal Dis. 2010 Aug;25(8):941-7
pubmed: 20532535
Histopathology. 2010 Sep;57(3):395-409
pubmed: 20738418
Cancer Biol Ther. 2011 Jan 15;11(2):150-6
pubmed: 21191189
Asian Pac J Cancer Prev. 2010;11(5):1373-5
pubmed: 21198295
Cell Cycle. 2011 Jun 1;10(11):1794-809
pubmed: 21521946
Ann Oncol. 2012 Jan;23(1):135-41
pubmed: 21531784
Turk Patoloji Derg. 2012;28(1):61-6
pubmed: 22207434
Eur J Cancer. 2012 Mar;48(4):501-9
pubmed: 22226571
Cell Cycle. 2012 Mar 15;11(6):1108-17
pubmed: 22313602
Histopathology. 2012 Aug;61(2):162-9
pubmed: 22448644
Int J Cancer. 1993 Jul 30;54(6):1010-6
pubmed: 8335394
J Gastroenterol Hepatol. 1996 Jan;11(1):77-81
pubmed: 8672747

Auteurs

Sulen Sarioglu (S)

Faculty of Medicine, Department of Pathology, Dokuz Eylul University, Inciralti, Izmir, Turkey. sulen.sarioglu@deu.edu.tr.

Guray Akturk (G)

Faculty of Medicine, Department of Pathology, Dokuz Eylul University, Inciralti, Izmir, Turkey.
Memorial Sloan Kettering Cancer Center, Department of Pathology, Precision Pathology Biobanking Center, New York, USA.

Selman Sokmen (S)

Faculty of Medicine, Department of General Surgery, Dokuz Eylul University, Izmir, Turkey.

Hulya Ellidokuz (H)

Faculty of Medicine, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey.

Aras Emre Canda (AE)

Faculty of Medicine, Department of General Surgery, Dokuz Eylul University, Izmir, Turkey.

Mehtat Unlu (M)

Faculty of Medicine, Department of Pathology, Dokuz Eylul University, Inciralti, Izmir, Turkey.

Abdullah Haluk Sirin (AH)

Faculty of Medicine, Department of General Surgery, Dokuz Eylul University, Izmir, Turkey.

Ozgul Sagol (O)

Faculty of Medicine, Department of Pathology, Dokuz Eylul University, Inciralti, Izmir, Turkey.

Cem Terzi (C)

Faculty of Medicine, Department of General Surgery, Dokuz Eylul University, Izmir, Turkey.

Mehmet Fuzun (M)

Faculty of Medicine, Department of General Surgery, Dokuz Eylul University, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH